Study of SC-101 for advanced solid tumors
Part of Cancer clinical trials.
This trial tests a new drug called SC-101 in people with advanced solid tumors that have not responded to other treatments. It may be an option if your tumor shows a specific protein called Nectin-4, which the drug targets.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You have an advanced solid tumor that has been confirmed by biopsy and has not gotten better with other treatments.
- Your tumor must show Nectin-4 protein (if you join the expansion part of the study).
- You are able to do daily activities on your own (ECOG score 0 or 1).
- You have not had certain cancer treatments or surgeries in the past few weeks.
- You do not have serious medical conditions like uncontrolled infections, heart problems, or lung disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an experimental pill called GenSci122 for people with advanced solid tumors that have stopped responding to standard treatments. The goal is to see if the drug is safe and can help shrink tumors.
This early-phase trial tests a new drug (CD-001) for people with advanced solid tumors. It will check if the drug is safe, how the body handles it, and if it helps shrink tumors.
This trial tests a new drug called SC-102 in people with advanced solid tumors that have stopped responding to standard treatments. It aims to see if SC-102 is safe and how well it works.
This trial tests a new drug called SC-101 for people with advanced cancers that have a specific genetic change called NECTIN4 amplification. The drug targets this genetic change to try to stop the cancer from growing.
This trial tests a new drug called NP-101 for people with advanced solid tumors that have not responded to standard treatments. It aims to find the safest dose and see if it can shrink tumors.
This trial tests a new drug called 3SC009 for people with advanced solid tumors that have not responded to other treatments. The goal is to see if it is safe and effective.
Hear when a new Advanced Solid Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.